Pharmaceutical

Modi-Mundipharma R & D Centre (Modipuram)

The pharmaceutical operations had started in the year 1982 with Win-Medicare in collaboration with Sterling Drugs of USA. In 1989, Sterling Drug was sold to Eastman Kodak in the USA and this relationship came to an end. Post this, Umesh Modi group became a licensee of Mundipharma, A global (ex-US) network of independent associated companies that research, develop and manufacture innovative pharmaceutical medicines and consumer healthcare products for selling Betadine® range of products in India.

The association with Mundipharma was later on spun off into a 50:50 JV arrangement between Mundipharma group and Mr. Umesh K. Modi of the Umesh Modi Group of Industries, a leading business conglomerate in India.

Modi-Mundipharma group, through collaborations with the global players, is into gamut of healthcare business including Pharmaceuticals, Cosmetics, Nutrition, Phytopharmaceuticals & Consumer Health.

Reporting of Adverse Events :

To report an adverse experience and other product-related emergencies including overdose / product quality complaint with the use of any of our product please write to email id: pvg@winmedicare.com

We Are Here

Umesh Modi Group
1400, Modi Tower
98, Nehru Place, New Delhi-110019


Contact Us

Captcha Code